Morphic Holding - Stock Price History | MORF

Historical daily share price chart and data for Morphic Holding since 2021 adjusted for splits. The latest closing stock price for Morphic Holding as of September 23, 2021 is 64.71.
  • The all-time high Morphic Holding stock closing price was 84.85 on March 01, 2021.
  • The Morphic Holding 52-week high stock price is 93.00, which is 43.7% above the current share price.
  • The Morphic Holding 52-week low stock price is 24.94, which is 61.5% below the current share price.
  • The average Morphic Holding stock price for the last 52 weeks is 47.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Morphic Holding Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 22.8770 17.0600 34.5500 10.8400 33.5500 95.51%
2019 18.2828 18.0000 29.0500 13.0200 17.1600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.299B $0.045B
Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71